All Courses

This program meets the requirements outlined in Section 465.1895 , Florida Statutes for pharmacists who wish to enter into a collaborative practice agreement with a supervising physician in the State of Florida. Upon successful completion of the program, participants will earn a certificate of achievement from the University of Florida Office of Continuing Pharmacy Education.

This certificate training program focuses on topics related to collaborative practice agreements between pharmacists and physicians. This program will expand upon content included in the initial Collaborative Practice Agreement Program program. *This is not an ACPE-defined Certificate Program; learners who complete this course will receive ACPE CPE credit but will not be awarded completion of a Certificate Program.

This program is intended for pharmacists seeking to become a Florida licensed consultant pharmacist. This course will provide insight into regulatory requirements and clinical knowledge necessary to practice as a consultant pharmacist in the state of Florida.

This program is intended for licensed consultant pharmacists seeking continuing education for licensure renewal. This course will provide a review of regulatory requirements and clinical knowledge necessary to practice as a consultant pharmacist in the state of Florida.

This course is designed as a resource to help prepare the pharmacist for the responsibility of monitoring and managing anticoagulation therapy patients and clinics. It is also designed to serve as a starting point to help the pharmacist prepare for the Certified Anticoagulation Care Provider (CACP) exam. This program is approved by the Florida Board of Pharmacy for consultant pharmacist recertification credit.

This program is designed to equip the pharmacist with the knowledge necessary to implement pharmacogenomics into clinical practice in a variety of settings. Leading experts in the field of pharmacogenomics will provide educational content focusing on the following: background of pharmacogenomics, aspects of pharmacogenomic testing (laboratory considerations and interpretation of results), clinical implications of pharmacogenomics in multiple disease states including cardiology, oncology, pain management, and psychiatry, and adverse drug reactions (ADRs).

This program will identify the role of the pharmacist in ambulatory care settings, explore the importance of incorporating evidence-based practice into patient care, and review the treatment and management of various health conditions managed in the ambulatory care setting.

This program seeks to meet the requirements outlined in the Medication Access and Training Expansion (MATE) Act to provide training on the treatment and management of patients with opioid or other substance abuse disorders.

The Pharmacy-based Test and Treat certificate training program is a practice-based curriculum based on national educational standards that prepares pharmacists to provide point-of-care testing (POCT) and diagnostic services for minor, nonchronic health conditions that can be managed with minimal treatment or self-care. 

This certificate training program will prepare pharmacists with comprehensive knowledge, skills, and resources necessary to provide immunization services to patients across the life span.

This program includes an overview of the marketplace for delivering MTM services, guidance for implementing MTM services in pharmacy practice, a review of the essential skills and knowledge needed for performing MTM successfully, and an organized process for identifying medication-related problems. The purpose of this certificate training program is to prepare pharmacists to improve medication use through the delivery of MTM services in a variety of practice settings.

This certificate training program focuses on topics related to collaborative practice agreements between pharmacists and physicians. This program will expand upon content included in the initial Collaborative Practice Agreement Program program. *This is not an ACPE-defined Certificate Program; learners who complete this course will receive ACPE CPE credit but will not be awarded completion of a Certificate Program.

This activity will provide an overview of the medications used in the treatment of HIV. Specifically, discussed will be the different classes of antiretrovirals, including the mechanism of action, common side effects, drug-drug interactions, and limitations or special considerations which are unique to specific agents.

This continuing education program will provide guidance to practicing pharmacists and pharmacy technicians on the recognition of human trafficking and what subsequent action steps can be taken to best support victims of trafficking.

The validation, dispensing, and counseling of controlled substances by pharmacists is a critical intervention point for resisting opioid misuse and ensuring safe and effective healthcare for the public. This course is approved by the Florida Board of Pharmacy to fulfill the medication errors licensure renewal requirements outlined in Rule 64B16-26.103.

Pharmacists and pharmacy technicians are key members of the healthcare team who should understand the risks of medication errors and strategies to prevent them. This course is approved by the Florida Board of Pharmacy to fulfill the medication errors licensure renewal requirements outlined in Rule 64B16-26.103.

This Pharmacy-Based Test and Treat Recertification Course focuses on topics related to point-of-care testing and treatment for minor, non-chronic disease states between pharmacists and physicians in the state of Florida. *This is not an ACPE-defined Certificate Program; learners who complete this course will receive ACPE CPE credit but will not be awarded completion of a Certificate Program.

Pharmacists are often the most accessible healthcare providers, close to patients and embedded in their communities, with more than 90% of people in the U.S. living within five miles of a pharmacy. Because of this accessibility, pharmacists play a crucial role in controlling the HIV/AIDS epidemic, increasing timely access to HIV postexposure prophylaxis (PEP) to prevent infection.

This activity will build upon the HIV material covered within the Collaborative Practice Certification Program, introducing PEP guidelines for antiretroviral treatment following potential exposure to HIV. Upon completion of this activity, pharmacists providing services under a written collaborative practice agreement will have the clinical knowledge necessary to practice under an access-to-care plan, in which a collaborating physician authorizes the pharmacist to screen adults for HIV exposure or order and dispense HIV PEP under the written collaborative practice agreement.

This course will provide learners with a review of the treatment modalities associated with a variety of toxicological emergencies that are commonly managed in the acute care setting. Learners will have the opportunity to apply the content learned to develop patient-specific individualized treatment plans in the context of the toxicological emergencies reviewed in this primer.

Over the past decade, products derived from the leaves of the Kratom (Mitragyna speciosa) tree have gained popularity in the U.S. Kratom products are reported to be used for a range of self-treatment options including pain, mental disorders, mitigation of drug withdrawal symptoms, and mood elevation in general. This course will provide an overview of kratom’s known pharmacology, chemistry, pharmacokinetics, and use patterns.

The content of this program will provide the pharmacist with a review of thromboembolic risk factors and coagulation disorders. Utilizing current guidelines and recommendations, this program will provide the learner with the tools necessary to provide routine management of anticoagulant therapy in outpatient settings. Key concepts will be reinforced though case applications.

This program is designed to prepare pharmacists for the responsibility of counseling and educating patients and caregivers on signs of opioid overdose and naloxone use in order to improve patient access to naloxone. This program will describe the national overdose concerns associated with opioids, review proper administration of the available naloxone formulations, and describe the current naloxone access laws in place. 

Review the treatment and management of various infectious diseases that are commonly managed in the ambulatory care setting. Learners will have the opportunity to apply the content learned to develop patient-specific individualized treatment plans in the context of the disease states reviewed. 

Review the treatment and management of various endocrinology and bone health conditions that are commonly managed in the ambulatory care setting. Learners will have the opportunity to apply the content learned to develop patient-specific individualized treatment plans in the context of the disease states reviewed.

Review the treatment and management of various pulmonary conditions that are commonly managed in the ambulatory care setting. Learners will have the opportunity to apply the content learned to develop patient-specific individualized treatment plans in the context of the disease states reviewed. 

This CPE program will review the treatment and management of various cardiology health conditions that are commonly managed in the ambulatory care setting. Learners will have the opportunity to apply the content learned to develop patient-specific individualized treatment plans in the context of the disease states reviewed.

This course will update the pharmacist in the prevention and management of infectious diseases and issues that are important to the care of patients in such long-term settings.

Pharmacists have an important role in providing diabetes management. The content of this program will provide the pharmacist with a review of the pathophysiology of diabetes, oral an injectable diabetes medications and therapeutic plan development. 

This program provides an overview of antibiotic stewardship in hospitals, long-term care and outpatient facilities with the goal of empowering pharmacists to address the growing concern of inappropriate antibiotic use.